Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 2/6/2026

Hypertension Diagnosis, Classification, and Evidence‑Based Management

Blood Pressure Classification

  • Normal blood pressure is defined as a systolic/diastolic value < 120/80 mmHg. 1
  • Stage 1 hypertension is defined as 130–139 mmHg systolic or 80–89 mmHg diastolic. 1
  • Stage 2 hypertension is defined as ≥140 mmHg systolic or ≥90 mmHg diastolic. 2

Diagnostic Confirmation

  • Hypertension diagnosis requires out‑of‑office measurements: home blood pressure ≥ 135/85 mmHg or 24‑hour ambulatory blood pressure ≥ 130/80 mmHg. [2][3]5
  • Use validated automated upper‑arm cuff devices, measure both arms at the initial visit, and use the arm with the higher reading for all subsequent measurements. [2][6]

Lifestyle Modifications (Class I Recommendation)

  • All adults with elevated blood pressure or hypertension should adopt comprehensive lifestyle changes. 1
  • Sodium intake should be limited to < 2 g/day (≈ 5 g salt), with lower targets for older age groups. [4][7]
  • Daily potassium intake of ≥ 3.5 g is recommended. 7
  • Weight reduction to a body‑mass index of 18.5–24.9 kg/m² and waist circumference ≤ 102 cm (men) or ≤ 88 cm (women) is advised; each kilogram of weight loss lowers systolic pressure by roughly 1 mmHg. 1
  • Perform 30–60 minutes of moderate‑intensity aerobic exercise on 4–7 days per week. 4
  • Follow a DASH or Mediterranean dietary pattern emphasizing fruits, vegetables, low‑fat dairy, whole grains, plant proteins, and low saturated fat. [4][1]
  • Limit alcohol to ≤ 14 standard drinks/week for men and ≤ 9 drinks/week for women. 4

Immediate Pharmacologic Initiation

  • Patients with stage 2 hypertension (≥ 160/100 mmHg) should start drug therapy immediately, irrespective of cardiovascular risk. 9
  • For stage 1 hypertension (140–159/90–99 mmHg), immediate therapy is indicated when any of the following are present: clinical cardiovascular disease, prior stroke, chronic kidney disease, age 50–80 years, or a 10‑year atherosclerotic cardiovascular disease risk ≥ 7.5 %. [7][5][4][5]8

Delayed Pharmacologic Initiation (After 3–6 Months of Lifestyle Therapy)

  • In low‑to‑moderate risk patients with stage 1 hypertension whose blood pressure remains elevated after lifestyle measures, drug therapy may be initiated. 2
  • Thiazide or thiazide‑like diuretics (e.g., chlorthalidone, hydrochlorothiazide, indapamide). 7
  • Long‑acting dihydropyridine calcium‑channel blockers (e.g., amlodipine, nifedipine). 7
  • Angiotensin‑converting‑enzyme inhibitors (e.g., enalapril, lisinopril, ramipril). 7
  • Angiotensin‑II receptor blockers (e.g., candesartan, losartan, valsartan). 7

Race‑Based Therapeutic Considerations

  • Non‑Black patients: Begin with a low‑dose ACE inhibitor or ARB, add a dihydropyridine CCB, then a thiazide/ thiazide‑like diuretic as needed. 7
  • Black patients: Begin with a low‑dose ARB + CCB or CCB + thiazide combination; titrate to full dose, then add a diuretic or ACE inhibitor/ARB as a third agent. [7][3]

Fixed‑Dose Combination Therapy for Stage 2 Hypertension

  • Initiate a single‑pill fixed‑dose combination of two first‑line agents from different classes. [1][7]
  • This strategy improves medication adherence, shortens time to blood‑pressure control, and reduces side‑effects by allowing lower individual drug doses. [7][1]7
  • Routine combination of an ACE inhibitor with an ARB is contraindicated unless a compelling indication exists. [4][7]

Blood‑Pressure Targets

  • The primary treatment goal for most adults is a sustained blood pressure < 130/80 mmHg. [2][3][1][8]
  • Achieve the target within 3 months of therapy initiation. [2][6]
  • Aim for a minimum reduction of 20 mmHg systolic and 10 mmHg diastolic from baseline. [2][9]

Special Populations

  • Patients > 80 years or frail: Individualize goals; a target of < 140/90 mmHg is acceptable. 3
  • Patients with diabetes or chronic kidney disease: Maintain the stricter target of < 130/80 mmHg. 4
  • European Society of Cardiology (2024) recommendation: For most patients, aim for systolic 120–129 mmHg, with individualization for the very elderly or frail. 7

Treatment Intensification Algorithm

  • Step 3 – Triple Therapy: Add a third agent from the remaining major class (typically RAS blocker + CCB + thiazide) at full doses. [2][3]
  • Step 4 – Resistant Hypertension: First add spironolactone 25–50 mg daily; alternatives include eplerenone, amiloride, doxazosin, or vasodilating β‑blockers (labetalol, carvedilol, nebivolol). 2
  • Step 5 – Refractory Hypertension: Consider hydralazine, centrally acting agents (e.g., clonidine), α‑blockers, or referral to a hypertension specialist; reserve minoxidil for truly refractory cases. 7

Monitoring and Follow‑Up

  • Reassess blood‑pressure control at 3 months to verify target achievement. [2][6]
  • Home blood‑pressure monitoring combined with team‑based care improves control rates. 1
  • Verify medication adherence before escalating therapy. [2][6]
  • Refer to a hypertension specialist if blood pressure remains uncontrolled despite maximally tolerated triple therapy. [2][5]

Clinical Pitfalls to Avoid

  • Do not rely on cuffless (e.g., smartwatch) devices for blood‑pressure measurement due to poor accuracy. 1
  • Do not use β‑blockers as first‑line therapy except in patients < 60 years or those with compelling indications (coronary artery disease, heart failure). [4][7]
  • Do not routinely combine an ACE inhibitor with an ARB; this increases adverse events without added benefit. [4][7]
  • Do not delay treatment in high‑risk stage 1 hypertension; immediate pharmacotherapy reduces cardiovascular events. [1][8]
  • Avoid excessive blood‑pressure lowering in patients > 80 years, as it raises the risk of falls, syncope, and acute kidney injury. [2][1]

REFERENCES

← Return to Home